课题基金 / 基金详情

项目摘要

项目成果

JOEL S GREENBERGER的其他基金

相似基金

相关文献

中文摘要
翻译
匹兹堡大学CMCR的试点项目项目通过一个 高效的三层方法。最终目标是鼓励新的调查人员进入该领域 用于辐射缓释剂药物开发的辐射生物学。Louis Falo博士,Detcho Stoyanovsky,Jian Yu和陶成都在与试点项目获奖者合作的基础上获得了新的ROI奖励(表 1)或教育和发展核心资金(表2-3)。招募和征集试点项目申请, 以及通过UPCI-CMCR网站来的那些人最初是在电话中进行筛选的 和格林伯格医生的谈话。有些申请者被适当地劝阻,不愿花时间。 有必要提交一份完整的申请,通过这次电话交谈了解到这一目标 拟议的试点项目的目标与CMCR方案的目标不一致。这款一线电话 筛选技术得到了申请者的赞赏,因为格林伯格博士可以将他们引导到另一个 临床放射治疗相关项目的潜在试点项目资金来源,如试点项目 匹兹堡大学癌症研究所孢子项目肺癌或孢子 头颈癌项目。
英文摘要
The Pilots Project Program of the University of Pittsburgh CMCR manages pilot project applications by a highly efficient three-tiered approach. The ultimate goal is to encourage new investigators to enter the field of radiation biology for drug development of radiation mitigators. Drs. Louis Falo, Detcho Stoyanovsky, JIan Yu, and Tao Cheng all obtained new ROI grants based on collaboration with pilot project awardees (Table 1) or education and development core funding (Table 2-3). Recruited and solicited pilot project applications, as well as those coming through the UPCI-CMCR website were initially screened in a telephone conversation with Dr. Greenberger. Some applicants were appropriately discouraged from taking the time necessary to submit a full application, through this telephone conversation in which it was learned that goal of proposed pilot project was Inconsistent with the goals ofthe CMCR Program. This first tier telephone screening technique was appreciated by the applicants In that Dr. Greenberger could direct them to another potential source of pilot project funding for a clinical radiotherapy related project, such as the Pilot Project Program ofthe University of Pittsburgh Cancer Institute SPORE Program In Lung Cancer or SPORE Program in Head and Neck Cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LR-IL-22 for Mitigation and Management of Radiation Injuries
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotics LR-IL-22 and LR-IFN-β
  • 批准号:
    10380676
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    JOEL S GREENBERGER
  • 依托单位:
Mitochondrial Targeted Small Molecule Radiation Mitigators
Administrative Core
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: